Anti-il-20, anti-il-22 and anti-il-22ra antibodies and...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) C07K 14/715 (2006.01)

Patent

CA 2596390

The present invention relates to blocking, inhibiting, reduceing, antagonizing or neutralizing the activity of IL-22, IL-20, or both IL-20 and IL-22 polypeptide molecules. IL-20 and IL-22 are cytokines that are involved in inflammatory processes and human disease. IL-22RA (zcytor11) is a common receptor for IL-20 and IL-22. The present invention includes anti-IL-22RA antibodies and binding partners, as well as methods for antagonizing IL-22 or both IL-20 and IL-22 using such antibodies and binding partners.

L'invention concerne le blocage, l'inhibition, la réduction, l'antagonisation ou la neutralisation de l'activité de molécules polypeptidiques IL-22, IL-20, ou IL-20 et IL-22. IL-20 et IL-22 sont des cytokines impliquées dans des processus inflammatoires et dans des maladies humaines. IL-22RA (zcytor11) est un récepteur commun pour IL-20 et IL-22. L'invention concerne également des anticorps et des partenaires de liaison anti-IL-22RA, ainsi que des méthodes d'antagonisation d'IL-22 ou d'IL-20 et d'IL-22 au moyen de ces anticorps et partenaires de liaison.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-il-20, anti-il-22 and anti-il-22ra antibodies and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-il-20, anti-il-22 and anti-il-22ra antibodies and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-il-20, anti-il-22 and anti-il-22ra antibodies and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2025392

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.